Ravi Kalhan, MD, MS
Disclosures: Consulting Fee-GlaxoSmithKline|Consulting Fee-CVS Caremark (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CSA Medical|Consulting Fee-AstraZeneca - 08/03/2022
No Bio Available.